Fraxin

CAS# 524-30-1

Fraxin

Catalog No. BCN1237----Order now to get a substantial discount!

Product Name & Size Price Stock
Fraxin: 5mg $12 In Stock
Fraxin: 10mg Please Inquire In Stock
Fraxin: 20mg Please Inquire Please Inquire
Fraxin: 50mg Please Inquire Please Inquire
Fraxin: 100mg Please Inquire Please Inquire
Fraxin: 200mg Please Inquire Please Inquire
Fraxin: 500mg Please Inquire Please Inquire
Fraxin: 1000mg Please Inquire Please Inquire

Quality Control of Fraxin

Number of papers citing our products

Chemical structure

Fraxin

3D structure

Chemical Properties of Fraxin

Cas No. 524-30-1 SDF Download SDF
PubChem ID 5281418 Appearance White powder
Formula C16H18O10 M.Wt 370.32
Type of Compound Coumarins Storage Desiccate at -20°C
Synonyms 7,8-Dihydroxy 6-methoxycoumarin 8-β-D-glucopyranoside; Fraxetin 8-β-D-glucopyranoside; Fraxetol 8-glucoside; Fraxoside
Solubility DMSO : 250 mg/mL (675.11 mM; Need ultrasonic)
Chemical Name 7-hydroxy-6-methoxy-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one
SMILES COC1=C(C(=C2C(=C1)C=CC(=O)O2)OC3C(C(C(C(O3)CO)O)O)O)O
Standard InChIKey CRSFLLTWRCYNNX-YJDQBUFVSA-N
Standard InChI InChI=1S/C16H18O10/c1-23-7-4-6-2-3-9(18)25-14(6)15(11(7)20)26-16-13(22)12(21)10(19)8(5-17)24-16/h2-4,8,10,12-13,16-17,19-22H,5H2,1H3/t8-,10-,12-,13-,16+/m1/s1
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Source of Fraxin

1 Fraxinus sp. 2 Symphoricarpus sp. 3 Tilia sp.

Biological Activity of Fraxin

DescriptionFraxin possesses a variety of bioactivities such as anti-inflammatory, antioxidant, analgesic, antimicrobial, antiviral, immunomodulatory, anti-hyperuricemia and diuresis. Fraxin enhances urate excretion partly by inhibiting mURAT1 or mGLUT9 in kidney of hyperuricemic mice.
TargetsGLUT | mURAT1 | mOAT1 | mOCT1
In vitro

Natural compounds,fraxin and chemicals structurally related to fraxin protect cells from oxidative stress.[Pubmed: 16264268]

Exp Mol Med. 2005 Oct 31;37(5):436-46.

Coumarins comprise a group of natural phenolic compounds found in a variety of plant sources. In view of the established low toxicity, relative cheapness, presence in the diet and occurrence in various herbal remedies of coumarins, it appears prudent to evaluate their properties and applications further.
METHODS AND RESULTS:
The purpose of this study is to investigate cellular protective activity of coumarin compound, Fraxin extracted from Weigela florida var. glabbra, under oxidative stress, to identify genes expressed differentially by Fraxin and to compare antioxidative effect of Fraxin with its structurally related chemicals. Of the coumarins, protective effects of Fraxin against cytotoxicity induced by H2O2 were examined in human umbilical vein endothelial cells (HUVECs). Fraxin showed free radical scavenging effect at high concentration (0.5 mM) and cell protective effect against H2O2-mediated oxidative stress. Fraxin recovered viability of HUVECs damaged by H2O2-treatment and reduced the lipid peroxidation and the internal reactive oxygen species level elevated by H2O2 treatment. Differential display reverse transcription-PCR revealed that Fraxin upregulated antiapoptotic genes (clusterin and apoptosis inhibitor 5) and tumor suppressor gene (ST13). Based on structural similarity comparing with Fraxin, seven chemicals, fraxidin methyl ether (29.4% enhancement of viability), prenyletin (26.4%), methoxsalen (20.8%), diffratic acid (19.9%), rutoside (19.1%), xanthyletin (18.4%), and kuhlmannin (18.2%), enhanced more potent cell viability in the order in comparison with Fraxin, which showed only 9.3% enhancement of cell viability.
CONCLUSIONS:
These results suggest that Fraxin and Fraxin-related chemicals protect HUVECs from oxidative stress.

In vivo

Metabolic fate of fraxin administered orally to rats.[Pubmed: 16724835]

J Nat Prod. 2006 May;69(5):755-7.


METHODS AND RESULTS:
Naturally occurring Fraxin (1) was administered orally to rats to investigate its metabolism. Urinary metabolites were analyzed by three-dimensional HPLC, and fraxetin-7-O-sulfate (2), fraxetin-7-O-beta-glucuronide (3), fraxetin (4), 6,7,8-trihydroxycoumarin (5), and fraxidin (6) were isolated. Fraxin (1) was extensively metabolized to 4, which was partly metabolized to 5 in a rat fecal suspension after incubation for 24 h. Urinary excretion of 4 and 5 in rats administered orally with 1 was substantially reduced when the rats were treated with antibiotics to suppress their intestinal flora. Incubation of 1 with a rat liver S-9 mixture yielded 6.
CONCLUSIONS:
These results suggest that hydrolysis and demethylation of 1 are performed by intestinal microflora, while methylation occurs in the liver.

Protective effects of cortex fraxini coumarines against oxonate-induced hyperuricemia and renal dysfunction in mice.[Pubmed: 21620826]

Eur J Pharmacol. 2011 Sep;666(1-3):196-204.

The aim of the present study was to investigate the effects of cortex Fraxini coumarines esculetin, esculin, fraxetin and Fraxin on renal dysfunction and expression abnormality of renal organic ion transporters in hyperuricemic animals.
METHODS AND RESULTS:
Mice were orally given 250 mg/kg oxonate for seven consecutive days to induce hyperuricemia and renal dysfunction. After 1h of oxonate induction daily, animals were orally treated with esculetin, esculin, fraxetin and Fraxin at 20 and 40 mg/kg, respectively. Esculetin, esculin, fraxetin and Fraxin significantly decreased serum urate, creatinine and blood urea nitrogen levels and increased urine urate and creatinine excretion in hyperuricemic mice. Esculetin and esculin up-regulated expressions of renal organic anion transporter 1 (mOAT1), organic cation and carnitine transporters (mOCT1-2 and mOCTN1-2), but failed to affect renal glucose transporter 9 (mGLUT9) and urate transporter 1 (mURAT1) in this model. Fraxetin specifically inhibited renal mURAT1, while Fraxin extensively interacted with renal mGLUT9, mURAT1, mOAT1 and mOCT1 in hyperuricemic mice. Furthermore, esculetin, fraxetin and Fraxin increased mABCG2 mRNA expression and decreased its protein levels in renal apical membrane in hyperuricemic mice.
CONCLUSIONS:
These results indicate that esculetin and esculin have beneficial effects on hyperuricemia and renal dysfunction, resulting in restoration of mOAT1, mOCT1-2 and mOCTN1-2, and fraxetin and Fraxin enhance urate excretion partly by inhibiting mURAT1 or mGLUT9 in kidney of hyperuricemic mice. Regulation of mABCG2 by cortex Fraxini coumarines may be partly contributed to their beneficial actions. This study provides an evidence to support clinical therapeutic effects of cortex Fraxini coumarines on hyperuricemia with renal dysfunction.

Protocol of Fraxin

Structure Identification
Biomed Chromatogr. 2005 Nov;19(9):696-702.

Non-aqueous capillary electrophoresis for separation and simultaneous determination of fraxin, esculin and esculetin in Cortex fraxini and its medicinal preparations.[Pubmed: 15828063]


METHODS AND RESULTS:
A non-aqueous capillary electrophoresis method has been developed for the separation and simultaneous determination of Fraxin, esculin and esculetin in Cortex Fraxini and its preparation for the first time. Optimum separation of the analytes was obtained on a 47 cm x 75 microm i.d. fused-silica capillary using a non-aqueous buffer system of 60 mM sodium cholate, 20 mM ammonium acetate, 20% acetonitrile and 3% acetic acid at 20 kV and 292 K, respectively. The relative standard deviations (RSDs) of the migration times and the peak heights of the three analytes were in the range of 0.23-0.28 and 2.12-2.60%, respectively. Detection limits of Fraxin, esculin and esculetin were 0.1557, 0.4073 and 0.5382 microg/mL, respectively. In the tested concentration range, good linear relationships (correlation coefficients 0.9995 for Fraxin, 0.9999 for esculin and 0.9992 for esculetin) between peak heights and concentrations of the analytes were observed.
CONCLUSIONS:
This method has been successfully applied to simultaneous determination of the three bioactive components with the recoveries from 90.2 to 109.2% in the five samples.

Fraxin Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

Fraxin Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of Fraxin

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 2.7004 mL 13.5018 mL 27.0037 mL 54.0073 mL 67.5092 mL
5 mM 0.5401 mL 2.7004 mL 5.4007 mL 10.8015 mL 13.5018 mL
10 mM 0.27 mL 1.3502 mL 2.7004 mL 5.4007 mL 6.7509 mL
50 mM 0.054 mL 0.27 mL 0.5401 mL 1.0801 mL 1.3502 mL
100 mM 0.027 mL 0.135 mL 0.27 mL 0.5401 mL 0.6751 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University
Featured Products
New Products
 

References on Fraxin

Metabolic fate of fraxin administered orally to rats.[Pubmed:16724835]

J Nat Prod. 2006 May;69(5):755-7.

Naturally occurring Fraxin (1) was administered orally to rats to investigate its metabolism. Urinary metabolites were analyzed by three-dimensional HPLC, and fraxetin-7-O-sulfate (2), fraxetin-7-O-beta-glucuronide (3), fraxetin (4), 6,7,8-trihydroxycoumarin (5), and fraxidin (6) were isolated. Fraxin (1) was extensively metabolized to 4, which was partly metabolized to 5 in a rat fecal suspension after incubation for 24 h. Urinary excretion of 4 and 5 in rats administered orally with 1 was substantially reduced when the rats were treated with antibiotics to suppress their intestinal flora. Incubation of 1 with a rat liver S-9 mixture yielded 6. These results suggest that hydrolysis and demethylation of 1 are performed by intestinal microflora, while methylation occurs in the liver.

Non-aqueous capillary electrophoresis for separation and simultaneous determination of fraxin, esculin and esculetin in Cortex fraxini and its medicinal preparations.[Pubmed:15828063]

Biomed Chromatogr. 2005 Nov;19(9):696-702.

A non-aqueous capillary electrophoresis method has been developed for the separation and simultaneous determination of Fraxin, esculin and esculetin in Cortex Fraxini and its preparation for the first time. Optimum separation of the analytes was obtained on a 47 cm x 75 microm i.d. fused-silica capillary using a non-aqueous buffer system of 60 mM sodium cholate, 20 mM ammonium acetate, 20% acetonitrile and 3% acetic acid at 20 kV and 292 K, respectively. The relative standard deviations (RSDs) of the migration times and the peak heights of the three analytes were in the range of 0.23-0.28 and 2.12-2.60%, respectively. Detection limits of Fraxin, esculin and esculetin were 0.1557, 0.4073 and 0.5382 microg/mL, respectively. In the tested concentration range, good linear relationships (correlation coefficients 0.9995 for Fraxin, 0.9999 for esculin and 0.9992 for esculetin) between peak heights and concentrations of the analytes were observed. This method has been successfully applied to simultaneous determination of the three bioactive components with the recoveries from 90.2 to 109.2% in the five samples.

Protective effects of cortex fraxini coumarines against oxonate-induced hyperuricemia and renal dysfunction in mice.[Pubmed:21620826]

Eur J Pharmacol. 2011 Sep;666(1-3):196-204.

The aim of the present study was to investigate the effects of cortex Fraxini coumarines esculetin, esculin, fraxetin and Fraxin on renal dysfunction and expression abnormality of renal organic ion transporters in hyperuricemic animals. Mice were orally given 250 mg/kg oxonate for seven consecutive days to induce hyperuricemia and renal dysfunction. After 1h of oxonate induction daily, animals were orally treated with esculetin, esculin, fraxetin and Fraxin at 20 and 40 mg/kg, respectively. Esculetin, esculin, fraxetin and Fraxin significantly decreased serum urate, creatinine and blood urea nitrogen levels and increased urine urate and creatinine excretion in hyperuricemic mice. Esculetin and esculin up-regulated expressions of renal organic anion transporter 1 (mOAT1), organic cation and carnitine transporters (mOCT1-2 and mOCTN1-2), but failed to affect renal glucose transporter 9 (mGLUT9) and urate transporter 1 (mURAT1) in this model. Fraxetin specifically inhibited renal mURAT1, while Fraxin extensively interacted with renal mGLUT9, mURAT1, mOAT1 and mOCT1 in hyperuricemic mice. Furthermore, esculetin, fraxetin and Fraxin increased mABCG2 mRNA expression and decreased its protein levels in renal apical membrane in hyperuricemic mice. These results indicate that esculetin and esculin have beneficial effects on hyperuricemia and renal dysfunction, resulting in restoration of mOAT1, mOCT1-2 and mOCTN1-2, and fraxetin and Fraxin enhance urate excretion partly by inhibiting mURAT1 or mGLUT9 in kidney of hyperuricemic mice. Regulation of mABCG2 by cortex Fraxini coumarines may be partly contributed to their beneficial actions. This study provides an evidence to support clinical therapeutic effects of cortex Fraxini coumarines on hyperuricemia with renal dysfunction.

Description

Fraxin isolated from Acer tegmentosum, F. ornus or A. hippocastanum, is a glucoside of fraxetin and reported to exert potent anti-oxidative stress action, anti-inflammatory and antimetastatic properties. Fraxin shows its antioxidative effect through inhibition of cyclo AMP phosphodiesterase enzyme.

Keywords:

Fraxin,524-30-1,7,8-Dihydroxy 6-methoxycoumarin 8-β-D-glucopyranoside; Fraxetin 8-β-D-glucopyranoside; Fraxetol 8-glucoside; Fraxoside,Natural Products, buy Fraxin , Fraxin supplier , purchase Fraxin , Fraxin cost , Fraxin manufacturer , order Fraxin , high purity Fraxin

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: